# Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access

Study · id `cardio:ct-nct07858331` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07858331](<https://clinicaltrials.gov/study/NCT07858331>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07858331

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 880 participants.

## Technical summary

Registry record NCT07858331. Randomized; no masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2029-01-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 880 participants (planned count; ClinicalTrials.gov record NCT07858331, source copy `cardio:ctgov-nct07858331-2026-10-05`, retrieved 2026-10-26)
- Planned start: 2027-01-01 (anticipated) (ClinicalTrials.gov record NCT07858331, source copy `cardio:ctgov-nct07858331-2026-10-05`, retrieved 2026-10-26)
- Primary completion: 2029-01-01 (anticipated) (ClinicalTrials.gov record NCT07858331, source copy `cardio:ctgov-nct07858331-2026-10-05`, retrieved 2026-10-26)
- Completion: 2029-01-01 (anticipated) (ClinicalTrials.gov record NCT07858331, source copy `cardio:ctgov-nct07858331-2026-10-05`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT07858331, source copy `cardio:ctgov-nct07858331-2026-10-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07858331-2026-10-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access
- Acronym: PIVOT
- Condition: Obesity
- Condition: Chronic Kidney Disease
- Condition: Chronic Renal Disease
- Condition: CKD
- Intervention (Drug): Semaglutide
- Intervention (Behavioral): Virtual Weight Management Coaching
- Lead sponsor: Kristin Clemens
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry intervention name matches this record: Semaglutide (`cardio:semaglutide`)

## Provenance

Content hash: d3e1e4523685e2d59c9b296289764d8a45284ae4f9bce6b7c51cc7a30533406d
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
